rs61762966
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020750.3(XPO5):c.241G>A(p.Gly81Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0023 in 1,613,814 control chromosomes in the GnomAD database, including 51 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_020750.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020750.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| XPO5 | TSL:1 MANE Select | c.241G>A | p.Gly81Ser | missense | Exon 3 of 32 | ENSP00000265351.7 | Q9HAV4 | ||
| XPO5 | c.241G>A | p.Gly81Ser | missense | Exon 3 of 32 | ENSP00000613468.1 | ||||
| XPO5 | c.241G>A | p.Gly81Ser | missense | Exon 3 of 32 | ENSP00000613472.1 |
Frequencies
GnomAD3 genomes AF: 0.0107 AC: 1628AN: 152032Hom.: 27 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00314 AC: 783AN: 249244 AF XY: 0.00271 show subpopulations
GnomAD4 exome AF: 0.00142 AC: 2077AN: 1461664Hom.: 24 Cov.: 30 AF XY: 0.00130 AC XY: 945AN XY: 727120 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0107 AC: 1627AN: 152150Hom.: 27 Cov.: 32 AF XY: 0.0102 AC XY: 757AN XY: 74392 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.